FLAM
VERA icon

First Light Asset Management’s Vera Therapeutics VERA Stock Holding History

First Light Asset Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-313,906
Closed -$12.6M – 35
2026
Q1 		$12.6M Sell
313,906
-555,770
-64% -$23.9M 1.13% 28
2025
Q4 		$44M Buy
869,676
+362,579
+72% +$12.9M 3.37% 8
2025
Q3 		$14.7M Sell
507,097
-55,884
-10% -$1.29M 1.39% 27
2025
Q2 		$13.3M Sell
562,981
-612,898
-52% -$13.8M 1.72% 20
2025
Q1 		$28.2M Sell
1,175,879
-85,367
-7% -$2.74M 3.23% 12
2024
Q4 		$53.3M Buy
1,261,246
+556,012
+79% +$24.6M 5.1% 6
2024
Q3 		$31.2M Sell
705,234
-300,489
-30% -$11.4M 2.59% 20
2024
Q2 		$36.4M Buy
1,005,723
+569,590
+131% +$22.6M 3.19% 15
2024
Q1 		$18.8M Buy
+436,133
New +$15.5M 1.44% 30

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

First Light Asset Management's VERA Position: Q2 2026 in Review

First Light Asset Management sold out of Vera Therapeutics (VERA) in Q2 2026, closing a stake of 313,906 shares — an estimated $12.6M sold.

First Light Asset Management first reported a position in VERA in Q1 2024 and held it in 9 quarters. The position peaked at $53.3M in Q4 2024. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • First Light Asset Management reported no remaining Vera Therapeutics position as of Q2 2026 after selling out during the quarter.
  • First Light Asset Management sold 313,906 Vera Therapeutics shares in Q2 2026, an estimated $12.6M.
  • First Light Asset Management first reported a position in Vera Therapeutics in Q1 2024 and held it in 9 quarters.
  • First Light Asset Management's Vera Therapeutics position peaked at $53.3M in Q4 2024.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on First Light Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.